Variables | Scenario 1 | Scenario 2 | Scenario 3 | |||
---|---|---|---|---|---|---|
 | pvalue | HR (95% CI) | pvalue | HR (95% CI) | pvalue | HR (95% CI) |
Age (10 years) | <.0001 | 1.489 (1.436–1.545) | <.0001 | 1.385 (1.330–1.443) | <.0001 | 1.430 (1.363–1.501) |
Male | <.0001 | 2.222 (1.929–2.559) | <.0001 | 2.145 (1.845–2.494) | <.0001 | 2.056 (1.741–2.427) |
Diabetes mellitus | <.0001 | 1.456 (1.234–1.719) | <.0001 | 1.416 (1.189–1.687) | 0.0163 | 1.256 (1.043–1.513) |
Oral corticosteroids (g) | 0.0004 | 1.171 (1.073–1.279) | 0.0028 | 1.157 (1.051–1.273) | <.0001 | 1.185 (1.097–1.281) |
Oral beta-agonists (30 DDD) | 0.0007 | 1.056 (1.023–1.090) | 0.0115 | 1.071 (1.015–1.130) | 0.0029 | 1.051 (1.017–1.087) |
Inhaled SAMA* (30 DDD) | 0.001 | 1.043 (1.017–1.069) | 0.0053 | 1.039 (1.011–1.068) |  |  |
Acute exacerbations | 0.0008 | 1.026 (1.011–1.042) | 0.0127 | 1.021 (1.004–1.038) |  |  |
Low income |  |  |  |  | 0.0027 | 1.8 (1.225–1.644) |